Cite
Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics.
MLA
He, S. W., et al. “Influence of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Nitric Oxide Production in Hypertensives and Hypercholesterolaemics.” Journal of Clinical Pharmacy & Therapeutics, vol. 36, no. 2, Apr. 2011, pp. 187–93. EBSCOhost, https://doi.org/10.1111/j.1365-2710.2010.01176.x.
APA
He, S. W., Huang, H. W., Tan, S. Q., Fu, X., Su, L. L., Peng, D. X., Lin, R. J., & Wong, K. S. (2011). Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics. Journal of Clinical Pharmacy & Therapeutics, 36(2), 187–193. https://doi.org/10.1111/j.1365-2710.2010.01176.x
Chicago
He, S. W., H. W. Huang, S. Q. Tan, X. Fu, L. L. Su, D. X. Peng, R. J. Lin, and K. S. Wong. 2011. “Influence of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Nitric Oxide Production in Hypertensives and Hypercholesterolaemics.” Journal of Clinical Pharmacy & Therapeutics 36 (2): 187–93. doi:10.1111/j.1365-2710.2010.01176.x.